Author: Customer Service

WASHINGTON, June 09, 2026 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of former healthcare executive Sean O’Reilly as a Senior Managing Director in the firm’s Healthcare Risk Management & Advisory practice. Mr. O’Reilly brings more than 25 years of experience advising healthcare organizations on compliance program design, regulatory risk management and operational integrity across a range of healthcare sectors, including Medicare Advantage, Medicaid, employer group medical and specialty insurance, military healthcare, hospice, home health, value-based primary care and pharmacy. In his role at FTI Consulting, Mr. O’Reilly will advise clients on the design, implementation and improvement of enterprise compliance programs, focusing on risk identification, control development and regulatory...

MINNEAPOLIS, June 09, 2026 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that Jared Oasheim, the Company’s Chief Financial Officer, will be stepping down from his role to pursue other professional opportunities. To support a seamless transition, Mr. Oasheim will remain with the Company until a successor is appointed and remain available as an advisor through February 2027. “Jared has been an integral part of CVRx since 2015, and has made a lasting mark on our company over the past decade” said Kevin Hykes, President and Chief Executive Officer of CVRx. “He led CVRx through its initial public offering and built the disciplined finance...

LOUISVILLE, Ky., June 09, 2026 (GLOBE NEWSWIRE) — Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage, media and AdTech solutions, today announced that it will be added to the Russell 3000® Index effective when the US market opens on June 29, 2026, as part of the Russell indexes reconstitution. The June reconstitution captures up to the 4,000 largest US stocks as of April 30, ranked by total market capitalization. Membership in the Russell 3000® Index, which remains in place for half a year, also means automatic inclusion in the small-cap Russell 2000® Index as well as the appropriate growth and value-style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization...

Preliminary Data Analysis Reveals Over 80% Remission Rate One Year after Accelerated Deep TMS Treatment, with Decline in Severe Functional Impairment from 85% to 0% BURLINGTON, Mass. and JERUSALEM, June 09, 2026 (GLOBE NEWSWIRE) — BrainsWay Ltd., a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the presentation of new prospective 12-month durability data demonstrating sustained clinical benefits following accelerated Deep Transcranial Magnetic Stimulation (Deep TMS™) for Major Depressive Disorder (MDD). The findings were recently presented in a poster by Colleen Hanlon, PhD, Vice President of Medical Affairs for BrainsWay, at the 14th Annual Clinical TMS Society (CTMSS) Meeting which was held on June 4-6, 2026. The data represented outcomes from the first multisite,...

Châtillon, France, June 9, 2026 DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT) (the “Company”), a late-stage biopharmaceutical company, today announced that company management will participate in 1-on-1 investor meetings at the Goldman Sachs 47th Annual Global Healthcare Conference on Tuesday, June 9, 2026, in Miami, FL. Mr. Daniel Tassé, CEO, will not be available for the previously scheduled fireside chat due to an unavoidable disruption of planned travel to the conference. About DBV TechnologiesDBV Technologies is a late-stage biopharmaceutical company developing treatment options for food allergies and other immunologic conditions with significant unmet medical need. DBV Technologies is currently...

Company Outlines Path Toward Integrated Testing and Independent Validation SOUTHLAKE, Texas, June 09, 2026 (GLOBE NEWSWIRE) — American Fusion Inc. (OTC: AMFN) (“American Fusion” or the “Company”), a company developing advanced fusion energy technologies, including its Texatron™ Fusion Engine™ platform, is pleased to provide shareholders with an update regarding the development and testing schedule for its 5MW Pre-Production Texatron™ Fusion Engine™. The Company continues to advance development activities associated with its 5MW pre-production platform and believes it is approaching a pivotal stage in the evolution of the Texatron™ Fusion Engine™ program. The upcoming testing campaign is intended to evaluate key system performance metrics, validate subsystem integration, and generate independent...

TORONTO, June 09, 2026 (GLOBE NEWSWIRE) — Lahontan Gold Corp. (TSXV:LG, OTCQB:LGCXF, FSE:Y2F) (the “Company” or “Lahontan“) is pleased to announce the first drill results from its 2026 drilling program at the Santa Fe Mine Project. The drill results reported herein cover four diamond core drill holes totalling 953 metres that were designed to acquire geotechnical data related to mine permitting that nonetheless intercepted significant gold mineralization. Five additional reverse-circulation (“RC”) drill holes, totalling 1,530 metres, have discovered a previously unrecognized zone of gold mineralization located west of the Slab open pit (“Slab West”) that remains open in all directions. Significant results are summarized below:Calvada: Drill hole CAL26-02C, originally designed to gather geotechnical data...

TORONTO, June 09, 2026 (GLOBE NEWSWIRE) — Fredonia Mining Inc. (“Fredonia” or the “Company”) (TSXV: FRED) is pleased to provide an update on recent corporate and technical developments as it continues to advance its flagship El Dorado Monserrat (“EDM”) Project in Santa Cruz Province, Argentina. Over the past several months, Fredonia has continued to execute key initiatives aimed at enhancing the value and long-term development potential of the EDM Project. Progress has been made across several areas, including the ongoing Preliminary Economic Assessment (“PEA”), strategic district consolidation efforts, and the evaluation of opportunities within the broader project area. “Our team has remained focused on creating long-term value through disciplined technical work, strategic land acquisitions and ongoing project evaluation. During...

Partnership supports reimbursement strategy and U.S. commercial expansion for Aclarion’s AI-driven platform for chronic low back pain. Program aims to follow successful reimbursement wins in the UK that are translating into sustained scan volume growth in step with reduced market access barriers BROOMFIELD, Colo., June 09, 2026 (GLOBE NEWSWIRE) — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today the launch of a Market Access Program in partnership with PRIA Healthcare. This initiative represents a significant step in Aclarion’s strategy to advance Nociscan®, the company’s proprietary AI-driven platform...

TORONTO, June 09, 2026 (GLOBE NEWSWIRE) — NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today announced that senior management will deliver a corporate presentation at the Sidoti Small Cap Conference on June 18, 2026, at 9:15 am ET. Interested parties can access the live presentation through the following link: Access Live Presentation The Company will also participate in one-on-one meetings at the virtual event on June 17th and June 18th, 2026. During the corporate presentation, NetraMark Chief Executive Officer, George Achilleos, intends to discuss the Company’s commercial, clinical, and regulatory progress with respect to NetraAI,...